An 85-year-old male with diarrhea, fecal calprotectin 278 µg/g, last colonoscopy on [date], and a negative Clostridioides difficile test—what should be the next steps in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management Recommendation

In this 85-year-old male with diarrhea, elevated fecal calprotectin (278 µg/g), and negative C. difficile testing, you should proceed with colonoscopy to evaluate for inflammatory bowel disease (IBD), microscopic colitis, ischemic colitis, segmental colitis associated with diverticulosis (SCAD), or colorectal malignancy 1, 2.

Diagnostic Rationale

The fecal calprotectin of 278 µg/g indicates significant intestinal inflammation and warrants endoscopic evaluation. While C. difficile is excluded, elderly patients presenting with diarrhea have a broader differential diagnosis than younger adults 1.

Key Differential Diagnoses in This Age Group

In patients over 60 years, the following conditions commonly mimic or coexist with IBD 1:

  • Inflammatory bowel disease (15% of new IBD diagnoses occur after age 60)
  • Microscopic colitis (particularly common in elderly)
  • Ischemic colitis
  • Segmental colitis associated with diverticulosis (SCAD)
  • Colorectal cancer
  • NSAID-induced enteropathy
  • Radiation colitis (if prior pelvic radiation)

Why Colonoscopy is Essential Now

The British Society of Gastroenterology guidelines specify that patients with intermediate to high suspicion for IBD, microscopic colitis, or colorectal neoplasia should undergo colonoscopy 2. Your patient meets these criteria with:

  • Elevated calprotectin (>50 µg/g threshold exceeded)
  • Age >60 years (higher malignancy risk)
  • Persistent diarrhea with documented inflammation

The AGA guidelines emphasize that elderly patients require "vigorous approach to confirming the diagnosis" because medical and surgical management varies substantially between these conditions 1.

Pre-Colonoscopy Workup

Before colonoscopy, complete the following 1:

  • Complete blood count (assess for anemia)
  • Serum albumin (malnutrition/protein-losing enteropathy)
  • C-reactive protein (systemic inflammation)
  • Serum ferritin (iron deficiency)
  • Liver enzymes, creatinine, urea (baseline for potential treatment toxicity monitoring)
  • Thyroid function tests (hyperthyroidism can cause diarrhea) 2
  • Tissue transglutaminase/EMA (celiac disease screening) 2

Consider CT Imaging

If abdominal pain is prominent or acute symptoms are present, obtain CT enterography or CT abdomen/pelvis before colonoscopy to evaluate for ischemic colitis, diverticular complications, or bowel wall thickening patterns 1.

Critical Pitfalls to Avoid

Do not assume this is post-infectious IBS or functional diarrhea despite negative C. difficile. The elevated calprotectin (278 µg/g) definitively indicates ongoing intestinal inflammation requiring tissue diagnosis 2.

Do not delay colonoscopy based on age alone. While some clinicians hesitate to pursue aggressive workup in octogenarians, the consequences of missing treatable IBD, microscopic colitis, or early-stage cancer significantly impact quality of life and mortality 1.

Ensure biopsies are obtained even if mucosa appears normal - microscopic colitis requires histologic confirmation and can present with normal-appearing mucosa on endoscopy 1, 2.

Special Consideration for Diverticulosis

If colonoscopy reveals segmental left-sided colitis in areas of diverticulosis, consider SCAD in addition to Crohn's disease or IBD-unclassified 1. This distinction matters because SCAD may respond to mesalamine or antibiotics rather than requiring immunosuppression.

Post-Colonoscopy Management Framework

Management depends entirely on histologic findings:

  • If IBD confirmed: Risk-stratify based on disease extent, albumin, inflammatory markers, and weight loss. In elderly patients, prefer gut-selective therapies (vedolizumab) or biologics with lower infection risk over thiopurines when immunosuppression is needed 1.

  • If microscopic colitis: Budesonide is first-line treatment.

  • If ischemic colitis: Supportive care, evaluate vascular risk factors.

  • If malignancy: Oncology referral for staging and treatment planning.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.